Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1970-12-22
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0008-543X
pubmed:author
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1000-5
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:4320033-Adenocarcinoma, pubmed-meshheading:4320033-Adenocarcinoma, Bronchiolo-Alveolar, pubmed-meshheading:4320033-Administration, Oral, pubmed-meshheading:4320033-Animals, pubmed-meshheading:4320033-Animals, Newborn, pubmed-meshheading:4320033-Bone Marrow, pubmed-meshheading:4320033-Brain Neoplasms, pubmed-meshheading:4320033-Cell Transformation, Neoplastic, pubmed-meshheading:4320033-Ependymoma, pubmed-meshheading:4320033-Female, pubmed-meshheading:4320033-Imidazoles, pubmed-meshheading:4320033-Lung Neoplasms, pubmed-meshheading:4320033-Lymph Nodes, pubmed-meshheading:4320033-Lymphatic Metastasis, pubmed-meshheading:4320033-Lymphoma, Non-Hodgkin, pubmed-meshheading:4320033-Mammary Neoplasms, Experimental, pubmed-meshheading:4320033-Rats, pubmed-meshheading:4320033-Sarcoma, Experimental, pubmed-meshheading:4320033-Splenic Neoplasms, pubmed-meshheading:4320033-Thymus Neoplasms
pubmed:year
1970
pubmed:articleTitle
induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent, 4 (5)-(3,3-dimethyl-1-triazeno) imidazole-5 (4)-carboxamide.
pubmed:publicationType
Journal Article